WithdrawnPhase 2

Bupivacaine Epiphora Trial

Stopped: No patients

United States0Started 2015-04

Plain-language summary

The objective of this study is to investigate quantitative improvement in excessive tearing after administration of Bupivacaine, a local anesthetic, into the affected eyelids.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: Patients age 18 and above, patients with unilateral or bilateral excessive tearing. Exclusion Criteria: Pregnant females, vulnerable populations, patients with severe hepatic disease, or patients using monoamine oxidase inhibitors or tricyclic antidepressants, which are contraindicated with bupivacaine and norepinephrine combinations.

What they're measuring

Change from Baseline Lacrimal Tear Lake at 6 months

Timeframe: measurements at baseline and 6 months

Trial details

NCT IDNCT03266081

SponsorMcMaster University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-08-23

View on ClinicalTrials.gov More Epiphora trials